These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37815547)

  • 21. Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression.
    Wang L; Wang Z; Zhu R; Bi J; Feng X; Liu W; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X
    PLoS One; 2017; 12(6):e0179476. PubMed ID: 28622392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of engineered conserved dopamine neurotrophic factor-expressing bone marrow stromal cells on dopaminergic neurons following 6-OHDA administrations.
    Mei J; Niu C
    Mol Med Rep; 2015 Feb; 11(2):1207-13. PubMed ID: 25373844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral Dopamine Neurotrophic Factor: A Potential Therapeutic Agent for Parkinson's Disease.
    Tang T; Li Y; Jiao Q; Du X; Jiang H
    Neurosci Bull; 2017 Oct; 33(5):568-575. PubMed ID: 28337696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral Dopamine Neurotrophic Factor Regulates Multiple Neuronal Subtypes and Behavior.
    Chen YC; Baronio D; Semenova S; Abdurakhmanova S; Panula P
    J Neurosci; 2020 Aug; 40(32):6146-6164. PubMed ID: 32631936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo.
    Albert K; Raymundo DP; Panhelainen A; Eesmaa A; Shvachiy L; Araújo GR; Chmielarz P; Yan X; Singh A; Cordeiro Y; Palhano FL; Foguel D; Luk KC; Domanskyi A; Voutilainen MH; Huttunen HJ; Outeiro TF; Saarma M; Almeida MS; Airavaara M
    Mol Ther; 2021 Sep; 29(9):2821-2840. PubMed ID: 33940158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicity.
    Wang L; Wang Z; Xu X; Zhu R; Bi J; Liu W; Feng X; Wu H; Zhang H; Wu J; Kong W; Yu B; Yu X
    Int J Med Sci; 2017; 14(4):340-347. PubMed ID: 28553166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigra.
    Nadella R; Voutilainen MH; Saarma M; Gonzalez-Barrios JA; Leon-Chavez BA; Jiménez JM; Jiménez SH; Escobedo L; Martinez-Fong D
    J Neuroinflammation; 2014 Dec; 11():209. PubMed ID: 25511018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDNF Interacts with ER Chaperones and Requires UPR Sensors to Promote Neuronal Survival.
    Eesmaa A; Yu LY; Göös H; Danilova T; Nõges K; Pakarinen E; Varjosalo M; Lindahl M; Lindholm P; Saarma M
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral dopamine neurotrophic factor-deficiency leads to degeneration of enteric neurons and altered brain dopamine neuronal function in mice.
    Lindahl M; Chalazonitis A; Palm E; Pakarinen E; Danilova T; Pham TD; Setlik W; Rao M; Võikar V; Huotari J; Kopra J; Andressoo JO; Piepponen PT; Airavaara M; Panhelainen A; Gershon MD; Saarma M
    Neurobiol Dis; 2020 Feb; 134():104696. PubMed ID: 31783118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral dopamine neurotrophic factor alleviates Aβ
    Zhou W; Chang L; Fang Y; Du Z; Li Y; Song Y; Hao F; Lv L; Wu Y
    Neurosci Lett; 2016 Oct; 633():40-46. PubMed ID: 27616705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesencephalic astrocyte-derived neurotrophic factor and cerebral dopamine neurotrophic factor: New endoplasmic reticulum stress response proteins.
    Liu H; Tang X; Gong L
    Eur J Pharmacol; 2015 Mar; 750():118-22. PubMed ID: 25637781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral Dopamine Neurotrophic Factor Diffuses Around the Brainstem and Does Not Undergo Anterograde Transport After Injection to the Substantia Nigra.
    Albert K; Renko JM; Mätlik K; Airavaara M; Voutilainen MH
    Front Neurosci; 2019; 13():590. PubMed ID: 31244598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cerebral dopamine neurotrophic factor on endogenous neural progenitor cell migration in a rat model of Parkinson's disease.
    Nasrolahi A; Mahmoudi J; Karimipour M; Akbarzadeh A; Sadigh-Eteghad S; Salehi R; Farajdokht F; Farhoudi M
    EXCLI J; 2019; 18():139-153. PubMed ID: 30956647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term protective effects of AAV9-mesencephalic astrocyte-derived neurotrophic factor gene transfer in parkinsonian rats.
    Hao F; Yang C; Chen SS; Wang YY; Zhou W; Hao Q; Lu T; Hoffer B; Zhao LR; Duan WM; Xu QY
    Exp Neurol; 2017 May; 291():120-133. PubMed ID: 28131727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trophic activities of endoplasmic reticulum proteins CDNF and MANF.
    Jӓntti M; Harvey BK
    Cell Tissue Res; 2020 Oct; 382(1):83-100. PubMed ID: 32845431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDNF protects the nigrostriatal dopamine system and promotes recovery after MPTP treatment in mice.
    Airavaara M; Harvey BK; Voutilainen MH; Shen H; Chou J; Lindholm P; Lindahl M; Tuominen RK; Saarma M; Hoffer B; Wang Y
    Cell Transplant; 2012; 21(6):1213-23. PubMed ID: 21943517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective and reparative effects of endoplasmic reticulum luminal proteins - mesencephalic astrocyte-derived neurotrophic factor and cerebral dopamine neurotrophic factor.
    Albert K; Airavaara M
    Croat Med J; 2019 Apr; 60(2):99-108. PubMed ID: 31044581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (1)H-, (13)C- and (15)N-NMR assignment of the N-terminal domain of human cerebral dopamine neurotrophic factor (CDNF).
    Latgé C; Cabral KM; Almeida MS; Foguel D
    Biomol NMR Assign; 2013 Apr; 7(1):101-3. PubMed ID: 22528768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of mutations and the association between polymorphisms in the cerebral dopamine neurotrophic factor (CDNF) gene and Parkinson disease.
    Choi JM; Hong JH; Chae MJ; Ngyuen PH; Kang HS; Ma HI; Kim YJ
    Neurosci Lett; 2011 Apr; 493(3):97-101. PubMed ID: 21320571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.